Skip to main content

Sema4 Holdings Corp. (SMFR)

NASDAQ: SMFR · IEX Real-Time Price · USD
7.80
+0.01 (0.13%)
After-hours:Oct 15, 2021 7:10 PM EDT
7.79
-0.43 (-5.23%)
At close: Oct 15, 4:00 PM
Market Cap1.87B
Revenue (ttm)n/a
Net Income (ttm)n/a
Shares Out443.87M
EPS (ttm)n/a
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume636,625
Open8.19
Previous Close8.22
Day's Range7.73 - 8.20
52-Week Range6.75 - 27.18
Betan/a
Analystsn/a
Price Targetn/a
Est. Earnings Daten/a

About SMFR

Sema4 Holdings Corp., doing business as Sema4, operates as a health information company that enhances diagnosis, treatment, and prevention of disease through data. The company provides Centrellis, an AI-driven health intelligence platform that delivers comprehensive insights to biopharma to accelerate the drug discovery, development, and commercialization life-cycle, as well as analytics for actionable insights, pre-clinical and clinical trial support, and advanced sequencing services. It also offers Sema4 Signal that enables and advances preci...

IndustryHealth Information Services
Founded2017
Employees3
Stock ExchangeNASDAQ
Ticker SymbolSMFR
Full Company Profile

Financial Performance

In 2020, Sema4 Holdings's revenue was $179.32 million, a decrease of -8.59% compared to the previous year's $196.17 million. Losses were -$241.34 million, 712.5% more than in 2019.

Financial Statements

News

Sema4 to Participate at Two Upcoming Investor Conferences in September

STAMFORD, Conn., Aug. 30, 2021 (GLOBE NEWSWIRE) -- Sema4 (Nasdaq: SMFR), an AI-driven genomic and clinical data intelligence platform company, today announced that Eric Schadt, Ph.D., Founder and Chief ...

1 month ago - GlobeNewsWire

Why Sema4 Holdings Stock Is Sinking Today

Investors weren't happy with the company's Q2 update.

2 months ago - The Motley Fool

Sema4 Reports Second Quarter 2021 Financial Results and Business Highlights

85% test-volume growth (excluding COVID-19 tests) compared to same period in 2020

2 months ago - GlobeNewsWire

Sema4 to Report Second Quarter 2021 Financial Results on Monday, August 16, 2021

STAMFORD, Conn., Aug. 02, 2021 (GLOBE NEWSWIRE) -- Sema4 (Nasdaq: SMFR), a patient-centered health intelligence company leveraging AI and machine learning to derive data-driven insights, today announced...

2 months ago - GlobeNewsWire

Sema4 to Participate at Two Upcoming Investor Conferences in August

STAMFORD, Conn., July 28, 2021 (GLOBE NEWSWIRE) -- Sema4 (Nasdaq: SMFR), a patient-centered health intelligence company leveraging AI and machine learning to derive data-driven insights, today announced...

2 months ago - GlobeNewsWire

Sema4 Closes Transaction with CM Life Sciences, Debuts as Publicly Traded AI-driven Genomic & Clinical Data Platform ...

STAMFORD, Conn., July 22, 2021 (GLOBE NEWSWIRE) -- Sema4 , a patient-centered health intelligence company leveraging AI and machine learning to derive data-driven insights, today announced the completio...

2 months ago - GlobeNewsWire

Former Magenta Therapeutics and Foundation Medicine CFO Jason Ryan to Join Sema4 Board of Directors

STAMFORD, Conn.--(BUSINESS WIRE)---- $CMLF #bioinformatics--Sema4, a patient-centered health intelligence company leveraging AI and machine learning to derive data-driven insights, today announced the a...

3 months ago - Business Wire

CM Life Sciences and Sema4 Announce Release of Definitive Proxy Statement for July 21 Shareholder Meeting to Vote on ...

NEW YORK--(BUSINESS WIRE)--CM Life Sciences (Nasdaq: CMLF), a special purpose acquisition company, or SPAC, sponsored by affiliates of Casdin Capital, LLC and Corvex Management LP, has filed its definit...

3 months ago - Business Wire

Sema4 Appoints Andrew Kasarskis, Health Data Expert and Precision Medicine Scientist, as Chief Data Officer

STAMFORD, Conn.--(BUSINESS WIRE)---- $CMLF #Bioinformatics--Sema4 appoints Andrew Kasarskis, PhD, to the newly established role of Chief Data Officer (CDO).

4 months ago - Business Wire

3 Stocks Cathie Wood Keeps Buying

After every trading session, Ark Invest's Cathie Wood shows which stocks she has bought and sold throughout the day.

Other symbols:COINPATH
4 months ago - The Dog of Wall Street

Sema4 and CM Life Sciences Announce the Filing of Amended Preliminary Proxy Statement

STAMFORD, Conn.--(BUSINESS WIRE)---- $CMLF #AI--The filing of the amended proxy statement marks the next step in the formal Securities and Exchange Commission (SEC) review process.

4 months ago - Business Wire

Cathie Wood's ARK Invest Buys Over 330,000 Shares of CM Life Sciences

One of ARK Invest exchange-traded funds run by ETF star Cathie Wood bought over 330,000 shares of CM Life Sciences Inc.

4 months ago - 24/7 Wall Street

AdventHealth and Sema4 Launch a Data-driven Precision Medicine Program to Optimize Patient Care and Outcomes

ORLANDO, Fla. and STAMFORD, Conn.--(BUSINESS WIRE)---- $CMLF #AI--AdventHealth is leveraging Sema4's health intelligence platform to enable a range of clinical and research initiatives

4 months ago - Business Wire

Sema4 to Participate in Upcoming Investor Conferences

STAMFORD, Conn.--(BUSINESS WIRE)---- $CMLF #AI--Sema4 executives, Eric Schadt (Founder & CEO) and Isaac Ro (CFO), will participate in fireside chats at two upcoming virtual investor conferences.

4 months ago - Business Wire

Sema4 and CM Life Sciences Announce the Filing of the Schedule-14A Proxy Statement in Connection with the Proposed Me...

STAMFORD, Conn.--(BUSINESS WIRE)---- $CMLF #AI--Sema4, a patient-centered health intelligence company leveraging AI and machine learning to derive data-driven insights, and CM Life Sciences (Nasdaq: CML...

5 months ago - Business Wire

CM Life Sciences Announces Filing of Amended Annual Report on Form 10-K Relating to Restatement of Financial Statemen...

NEW YORK--(BUSINESS WIRE)--CM Life Sciences, Inc. (NASDAQ:CMLF) today announced that it has filed with the Securities and Exchange Commission (SEC) an amended annual report on Form 10-K/A and a Form 8-K...

5 months ago - Business Wire

INVESTIGATION ALERT: Halper Sadeh LLP Investigates QELL, CMLF, AJAX, BOWX, SV; Shareholders are Encouraged to Contact...

NEW YORK, April 28, 2021 /PRNewswire/ -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: Qell Acquisition Corp. (NASDAQ: QELL)  concerning pot...

Other symbols:BOWXSV
5 months ago - PRNewsWire

NorthShore and Sema4 Launch System-Wide Genomics Program to Improve Primary and Specialty Care with Data-Driven Insights

EVANSTON, Ill. & STAMFORD, Conn.--(BUSINESS WIRE)---- $CMLF #CIO--NorthShore & Sema4 launch system-wise genomics program

5 months ago - Business Wire

SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of CM Life Sciences, Inc. - CMLF

NEW YORK, Feb. 12, 2021 /PRNewswire/ -- Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a national securities firm rated Top 50 in the 2018 and 2019 ISS Securities Class Act...

8 months ago - PRNewsWire

SHAREHOLDER ALERT: WeissLaw LLP Investigates CM Life Sciences, Inc.

NEW YORK, Feb. 11, 2021 /PRNewswire/ -- WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of CM Life Sciences, Inc. ("CMLF" or the "...

8 months ago - PRNewsWire

Keith Meister, Eli Casdin on new SPAC and data-driven health care

CNBC's "Halftime Report" team discusses the CM Life Sciences SPAC and the future of data-driven health care with Keith Meister of Corvex Capital and Eli Casdin of Casdin Capital.

8 months ago - CNBC Television

Sema4's Eric Schadt on health intelligence and going public via SPAC

CNBC's "Halftime Report" team discusses SPACs and the future of AI and data in the health care sector with Sema4 founder and CEO Eric Schadt. Sema4 is a patient-centered health intelligence company.

8 months ago - CNBC Television

CMLF Stock: 13 Things to Know About CM Life Sciences and the Sema4 SPAC Merger

CM Life Sciences (CMLF) stock is soaring higher on Wednesday after announcing plans to take Sema4 public via a SPAC merger. The post CMLF Stock: 13 Things to Know About CM Life Sciences and the Sema4 SP...

8 months ago - InvestorPlace

Sema4, a Disruptive AI-driven Genomic & Clinical Data Platform Company, to Combine with CM Life Sciences to Accelerat...

NEW YORK & STAMFORD, Conn.--(BUSINESS WIRE)--Sema4, an AI- and machine learning-driven patient-centered genomic and clinical data intelligence company, and CM Life Sciences (Nasdaq: CMLF), a special pur...

8 months ago - Business Wire